The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy
Related Experiment Video
Updated: Nov 9, 2026

05:13
Trabeculotome Tunneling Trabeculoplasty (3T): A Step-by-Step Surgical Protocol for Primary Open-angle Glaucoma
Published on: May 29, 2026
1Scheie Eye Institute, University of Pennsylvania, Philadelphia 19104.
Abstract:
Blockage of aqueous flow in the early postoperative period can be devastating to the success of trabeculectomy. We used tissue plasminogen activator (tPA) subconjunctivally in an attempt to release a trabeculectomy flap that appeared to be adherent to its scleral bed. No change was noted 90 minutes after injection, but a highly elevated bleb was present on the first postoperative day. Subconjunctivally administered tPA may be useful in releasing the fibrin "glue" in cases with adherent trabeculectomy flaps.
